Metronidazole Dosing for Intraabdominal Infections
For intraabdominal infections, the recommended dose of metronidazole is 500 mg intravenously every 8 hours. 1
Dosing Guidelines Based on Administration Route
Intravenous Administration
- The FDA-approved loading dose for IV metronidazole is 15 mg/kg infused over one hour (approximately 1 g for a 70-kg adult) 2
- Maintenance dose is 7.5 mg/kg infused over one hour every 6 hours (approximately 500 mg for a 70-kg adult) 2
- For intraabdominal infections specifically, the Infectious Diseases Society of America (IDSA) recommends 500 mg every 8 hours 1
- Duration of therapy is typically 7-10 days, though may be limited to 4-7 days if adequate source control is achieved 1
Special Considerations
- Patients with severe hepatic disease metabolize metronidazole more slowly, requiring lower doses and close monitoring of plasma levels 2
- In elderly patients, pharmacokinetics may be altered, necessitating serum level monitoring for dose adjustment 2
- For patients with continuous nasogastric aspiration, be aware that sufficient metronidazole may be removed to reduce serum levels 2
Combination Therapy for Intraabdominal Infections
- Metronidazole is typically used in combination with other antibiotics to provide adequate coverage against both aerobic and anaerobic pathogens 1, 3
- Common combinations include:
Special Clinical Scenarios
Fulminant Clostridium difficile Infection
- For fulminant C. difficile infection with ileus, intravenously administered metronidazole (500 mg every 8 hours) should be used in addition to oral or rectal vancomycin 1
- This is particularly important when ileus may impair delivery of oral vancomycin to the colon 1
Surgical Prophylaxis
- For surgical prophylaxis in contaminated or potentially contaminated colorectal surgery: 2
- 15 mg/kg infused over 30-60 minutes and completed approximately one hour before surgery
- Followed by 7.5 mg/kg infused over 30-60 minutes at 6 and 12 hours after the initial dose
Safety Considerations
- Prolonged or repeated courses of metronidazole should be avoided due to the risk of cumulative and potentially irreversible neurotoxicity 8
- Monitor for adverse effects, with the most common being nausea and diarrhea 3
- IV administration should be by slow intravenous drip infusion only, either continuous or intermittent 2
- Do not use equipment containing aluminum for administration 2